-
1
-
-
0037668545
-
Pathogenesis of systemic lupus erythematosus
-
10.1136/jcp.56.7.481, 1769989, 12835292
-
Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003, 56:481-490. 10.1136/jcp.56.7.481, 1769989, 12835292.
-
(2003)
J Clin Pathol
, vol.56
, pp. 481-490
-
-
Mok, C.C.1
Lau, C.S.2
-
2
-
-
0029994333
-
Systemic lupus erythematosus
-
10.1016/S0092-8674(00)81108-3, 8616885
-
Kotzin BL. Systemic lupus erythematosus. Cell 1996, 85:303-306. 10.1016/S0092-8674(00)81108-3, 8616885.
-
(1996)
Cell
, vol.85
, pp. 303-306
-
-
Kotzin, B.L.1
-
3
-
-
82555196095
-
Systemic lupus erythematosus
-
10.1056/NEJMra1100359, 22129255
-
Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110-2121. 10.1056/NEJMra1100359, 22129255.
-
(2011)
N Engl J Med
, vol.365
, pp. 2110-2121
-
-
Tsokos, G.C.1
-
5
-
-
76349107593
-
Pathogenesis of human systemic lupus erythematosus: recent advances
-
10.1016/j.molmed.2009.12.005, 2823952, 20138006
-
Crispin JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 2010, 16:47-57. 10.1016/j.molmed.2009.12.005, 2823952, 20138006.
-
(2010)
Trends Mol Med
, vol.16
, pp. 47-57
-
-
Crispin, J.C.1
Liossis, S.N.2
Kis-Toth, K.3
Lieberman, L.A.4
Kyttaris, V.C.5
Juang, Y.T.6
Tsokos, G.C.7
-
6
-
-
0018642145
-
Does corticosteroid-therapy affect the survival of patients with systemic lupus-erythematosus
-
10.1002/art.1780220901, 475873
-
Albert DA, Hadler NM, Ropes MW. Does corticosteroid-therapy affect the survival of patients with systemic lupus-erythematosus. Arthritis Rheum 1979, 22:945-953. 10.1002/art.1780220901, 475873.
-
(1979)
Arthritis Rheum
, vol.22
, pp. 945-953
-
-
Albert, D.A.1
Hadler, N.M.2
Ropes, M.W.3
-
7
-
-
84856463818
-
Treatment of systemic lupus erythematosus: new advances in targeted therapy
-
10.1111/j.1749-6632.2011.06263.x, 22236448
-
Lo MS, Tsokos GC. Treatment of systemic lupus erythematosus: new advances in targeted therapy. Ann N Y Acad Sci 2012, 1247:138-152. 10.1111/j.1749-6632.2011.06263.x, 22236448.
-
(2012)
Ann N Y Acad Sci
, vol.1247
, pp. 138-152
-
-
Lo, M.S.1
Tsokos, G.C.2
-
8
-
-
0022578857
-
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs
-
10.1056/NEJM198603063141004, 3511372
-
Austin HA, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986, 314:614-619. 10.1056/NEJM198603063141004, 3511372.
-
(1986)
N Engl J Med
, vol.314
, pp. 614-619
-
-
Austin, H.A.1
Klippel, J.H.2
Balow, J.E.3
le Riche, N.G.4
Steinberg, A.D.5
Plotz, P.H.6
Decker, J.L.7
-
9
-
-
0015104494
-
Cyclophosphamide in lupus nephritis: a controlled trial
-
Steinberg AD, Kaltreider HB, Staples PJ, Goetzl EJ, Talal N, Decker JL. Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med 1971, 75:165-171.
-
(1971)
Ann Intern Med
, vol.75
, pp. 165-171
-
-
Steinberg, A.D.1
Kaltreider, H.B.2
Staples, P.J.3
Goetzl, E.J.4
Talal, N.5
Decker, J.L.6
-
10
-
-
0025786860
-
Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
-
10.1002/art.1780340803, 1859488
-
Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 1991, 34:945-950. 10.1002/art.1780340803, 1859488.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 945-950
-
-
Steinberg, A.D.1
Steinberg, S.C.2
-
11
-
-
1642501086
-
The NIH pulse cyclophosphamide regime: the end of an era?
-
10.1191/0961203304lu524ed, 14870910
-
Karim Y, D'Cruz DP. The NIH pulse cyclophosphamide regime: the end of an era?. Lupus 2004, 13:1-3. 10.1191/0961203304lu524ed, 14870910.
-
(2004)
Lupus
, vol.13
, pp. 1-3
-
-
Karim, Y.1
D'Cruz, D.P.2
-
12
-
-
0037385330
-
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
-
Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
-
(2003)
Nat Immunol
, vol.4
, pp. 330-336
-
-
Fontenot, J.D.1
Gavin, M.A.2
Rudensky, A.Y.3
-
13
-
-
16844365788
-
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
-
Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
-
(2005)
Nat Immunol
, vol.6
, pp. 345-352
-
-
Sakaguchi, S.1
-
14
-
-
33846485153
-
Regulatory T cells prevent catastrophic aautoimmunity throughout the lifespan of mice
-
10.1038/ni1428, 17136045
-
Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic aautoimmunity throughout the lifespan of mice. Nat Immunol 2007, 8:191-197. 10.1038/ni1428, 17136045.
-
(2007)
Nat Immunol
, vol.8
, pp. 191-197
-
-
Kim, J.M.1
Rasmussen, J.P.2
Rudensky, A.Y.3
-
15
-
-
17144374934
-
Regulatory T-cell therapy: is it ready for the clinic?
-
10.1038/nri1574, 15775994
-
Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic?. Nat Rev Immunol 2005, 5:343-349. 10.1038/nri1574, 15775994.
-
(2005)
Nat Rev Immunol
, vol.5
, pp. 343-349
-
-
Bluestone, J.A.1
-
16
-
-
33750703169
-
[Regulatory T cells in rheumatic diseases]
-
10.1055/s-2006-951367, 17036273
-
Humrich J, Riemekasten G. [Regulatory T cells in rheumatic diseases]. Dtsch Med Wochenschr 2006, 131:2288-2291. 10.1055/s-2006-951367, 17036273.
-
(2006)
Dtsch Med Wochenschr
, vol.131
, pp. 2288-2291
-
-
Humrich, J.1
Riemekasten, G.2
-
17
-
-
33645819388
-
Regulatory T cells in human disease and their potential for therapeutic manipulation
-
10.1111/j.1365-2567.2006.02348.x, 1782265, 16630018
-
Taams LS, Palmer DB, Akbar AN, Robinson DS, Brown Z, Hawrylowicz CM. Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology 2006, 118:1-9. 10.1111/j.1365-2567.2006.02348.x, 1782265, 16630018.
-
(2006)
Immunology
, vol.118
, pp. 1-9
-
-
Taams, L.S.1
Palmer, D.B.2
Akbar, A.N.3
Robinson, D.S.4
Brown, Z.5
Hawrylowicz, C.M.6
-
18
-
-
47249124078
-
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
-
10.1111/j.1600-065X.2008.00637.x, 18613848
-
Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008, 223:371-390. 10.1111/j.1600-065X.2008.00637.x, 18613848.
-
(2008)
Immunol Rev
, vol.223
, pp. 371-390
-
-
Brusko, T.M.1
Putnam, A.L.2
Bluestone, J.A.3
-
19
-
-
44849089131
-
Human regulatory T cells and autoimmunity
-
10.1002/eji.200738104, 2752283, 18395861
-
Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol 2008, 38:921-924. 10.1002/eji.200738104, 2752283, 18395861.
-
(2008)
Eur J Immunol
, vol.38
, pp. 921-924
-
-
Costantino, C.M.1
Baecher-Allan, C.M.2
Hafler, D.A.3
-
20
-
-
74049164847
-
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
-
Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010, 11:7-13.
-
(2010)
Nat Immunol
, vol.11
, pp. 7-13
-
-
Wing, K.1
Sakaguchi, S.2
-
21
-
-
76249100290
-
Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus
-
10.1073/pnas.0903158107, 2806746, 20018660
-
Humrich JY, Morbach H, Undeutsch R, Enghard P, Rosenberger S, Weigert O, Kloke L, Heimann J, Gaber T, Brandenburg S, Scheffold A, Huehn J, Radbruch A, Burmester GR, Riemekasten G. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc Natl Acad Sci USA 2010, 107:204-209. 10.1073/pnas.0903158107, 2806746, 20018660.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 204-209
-
-
Humrich, J.Y.1
Morbach, H.2
Undeutsch, R.3
Enghard, P.4
Rosenberger, S.5
Weigert, O.6
Kloke, L.7
Heimann, J.8
Gaber, T.9
Brandenburg, S.10
Scheffold, A.11
Huehn, J.12
Radbruch, A.13
Burmester, G.R.14
Riemekasten, G.15
-
22
-
-
33846900430
-
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus
-
Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
-
(2007)
J Immunol
, vol.178
, pp. 2579-2588
-
-
Valencia, X.1
Yarboro, C.2
Illei, G.3
Lipsky, P.E.4
-
23
-
-
1342267617
-
Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus
-
10.1111/j.0300-9475.2004.01370.x, 14871297
-
Liu MF, Wang CR, Fung LL, Wu CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004, 59:198-202. 10.1111/j.0300-9475.2004.01370.x, 14871297.
-
(2004)
Scand J Immunol
, vol.59
, pp. 198-202
-
-
Liu, M.F.1
Wang, C.R.2
Fung, L.L.3
Wu, C.R.4
-
24
-
-
46849087978
-
Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus
-
Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 2008, 67:1037-1040.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1037-1040
-
-
Zhang, B.1
Zhang, X.2
Tang, F.L.3
Zhu, L.P.4
Liu, Y.5
Lipsky, P.E.6
-
25
-
-
29144516273
-
Global natural regulatory T cell depletion in active systemic lupus erythematosus
-
Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debre P, Piette JC, Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
-
(2005)
J Immunol
, vol.175
, pp. 8392-8400
-
-
Miyara, M.1
Amoura, Z.2
Parizot, C.3
Badoual, C.4
Dorgham, K.5
Trad, S.6
Nochy, D.7
Debre, P.8
Piette, J.C.9
Gorochov, G.10
-
26
-
-
33746214867
-
Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells
-
Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006, 177:1451-1459.
-
(2006)
J Immunol
, vol.177
, pp. 1451-1459
-
-
Scalapino, K.J.1
Tang, Q.2
Bluestone, J.A.3
Bonyhadi, M.L.4
Daikh, D.I.5
-
27
-
-
63149094153
-
Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus
-
Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol 2009, 182:1689-1695.
-
(2009)
J Immunol
, vol.182
, pp. 1689-1695
-
-
Bonelli, M.1
Savitskaya, A.2
Steiner, C.W.3
Rath, E.4
Smolen, J.S.5
Scheinecker, C.6
-
28
-
-
59449092041
-
Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
-
10.1182/blood-2008-07-168286, 18824594
-
Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S, Mei H, Radtke H, Gromnica-Ihle E, Burmester GR, Arnold R, Radbruch A, Hiepe F. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2009, 113:214-223. 10.1182/blood-2008-07-168286, 18824594.
-
(2009)
Blood
, vol.113
, pp. 214-223
-
-
Alexander, T.1
Thiel, A.2
Rosen, O.3
Massenkeil, G.4
Sattler, A.5
Kohler, S.6
Mei, H.7
Radtke, H.8
Gromnica-Ihle, E.9
Burmester, G.R.10
Arnold, R.11
Radbruch, A.12
Hiepe, F.13
-
29
-
-
0035525528
-
From T to B and back again: positive feedback in systemic autoimmune disease
-
10.1038/35100573, 11905822
-
Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001, 1:147-153. 10.1038/35100573, 11905822.
-
(2001)
Nat Rev Immunol
, vol.1
, pp. 147-153
-
-
Shlomchik, M.J.1
Craft, J.E.2
Mamula, M.J.3
-
30
-
-
33745062526
-
Adaptation of humoral memory
-
10.1111/j.0105-2896.2006.00380.x, 16824136
-
Hofer T, Muehlinghaus G, Moser K, Yoshida T, H EM, Hebel K, Hauser A, Hoyer B, E OL, Dorner T, Manz RA, Hiepe F, Radbruch A. Adaptation of humoral memory. Immunol Rev 2006, 211:295-302. 10.1111/j.0105-2896.2006.00380.x, 16824136.
-
(2006)
Immunol Rev
, vol.211
, pp. 295-302
-
-
Hofer, T.1
Muehlinghaus, G.2
Moser, K.3
Yoshida, T.4
H, E.M.5
Hebel, K.6
Hauser, A.7
Hoyer, B.8
E, O.L.9
Dorner, T.10
Manz, R.A.11
Hiepe, F.12
Radbruch, A.13
-
31
-
-
77953229472
-
T cells as therapeutic targets in SLE
-
10.1038/nrrheum.2010.60, 2924434, 20458333
-
Crispin JC, Kyttaris VC, Terhorst C, Tsokos GC. T cells as therapeutic targets in SLE. Nat Rev Rheumatol 2010, 6:317-325. 10.1038/nrrheum.2010.60, 2924434, 20458333.
-
(2010)
Nat Rev Rheumatol
, vol.6
, pp. 317-325
-
-
Crispin, J.C.1
Kyttaris, V.C.2
Terhorst, C.3
Tsokos, G.C.4
-
32
-
-
79952452617
-
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
-
Hiepe F, Dorner T, Hauser AE, Hoyer BF, Mei H, Radbruch A. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 2011, 7:170-178.
-
(2011)
Nat Rev Rheumatol
, vol.7
, pp. 170-178
-
-
Hiepe, F.1
Dorner, T.2
Hauser, A.E.3
Hoyer, B.F.4
Mei, H.5
Radbruch, A.6
-
33
-
-
2942635727
-
Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice
-
10.1084/jem.20040168, 2211779, 15173206
-
Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, Radbruch A, Hiepe F, Manz RA. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004, 199:1577-1584. 10.1084/jem.20040168, 2211779, 15173206.
-
(2004)
J Exp Med
, vol.199
, pp. 1577-1584
-
-
Hoyer, B.F.1
Moser, K.2
Hauser, A.E.3
Peddinghaus, A.4
Voigt, C.5
Eilat, D.6
Radbruch, A.7
Hiepe, F.8
Manz, R.A.9
-
34
-
-
0037868032
-
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition
-
Schiffer L, Sinha J, Wang X, Huang W, von Gersdorff G, Schiffer M, Madaio MP, Davidson A. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 2003, 171:489-497.
-
(2003)
J Immunol
, vol.171
, pp. 489-497
-
-
Schiffer, L.1
Sinha, J.2
Wang, X.3
Huang, W.4
von Gersdorff, G.5
Schiffer, M.6
Madaio, M.P.7
Davidson, A.8
-
35
-
-
0022273898
-
Murine models of systemic lupus erythematosus
-
Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985, 37:269-390.
-
(1985)
Adv Immunol
, vol.37
, pp. 269-390
-
-
Theofilopoulos, A.N.1
Dixon, F.J.2
-
36
-
-
6344268942
-
Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells
-
Riemekasten G, Langnickel D, Enghard P, Undeutsch R, Humrich J, Ebling FM, Hocher B, Humaljoki T, Neumayer H, Burmester GR, Hahn BH, Radbruch A, Hiepe F. Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J Immunol 2004, 173:5835-5842.
-
(2004)
J Immunol
, vol.173
, pp. 5835-5842
-
-
Riemekasten, G.1
Langnickel, D.2
Enghard, P.3
Undeutsch, R.4
Humrich, J.5
Ebling, F.M.6
Hocher, B.7
Humaljoki, T.8
Neumayer, H.9
Burmester, G.R.10
Hahn, B.H.11
Radbruch, A.12
Hiepe, F.13
-
38
-
-
84864821406
-
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis
-
10.1111/j.1365-2125.2012.04223.x, 22380717
-
Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL, Frye RF, Blaisdell J, Goldstein JA, Dooley MA, Brouwer KL, Falk RJ. Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol 2012, 74:445-455. 10.1111/j.1365-2125.2012.04223.x, 22380717.
-
(2012)
Br J Clin Pharmacol
, vol.74
, pp. 445-455
-
-
Joy, M.S.1
La, M.2
Wang, J.3
Bridges, A.S.4
Hu, Y.5
Hogan, S.L.6
Frye, R.F.7
Blaisdell, J.8
Goldstein, J.A.9
Dooley, M.A.10
Brouwer, K.L.11
Falk, R.J.12
-
39
-
-
77953025991
-
CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy
-
10.1016/j.clim.2010.02.020, 20338811
-
Cao Y, Zhao J, Yang Z, Cai Z, Zhang B, Zhou Y, Shen GX, Chen X, Li S, Huang B. CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy. Clin Immunol 2010, 136:21-29. 10.1016/j.clim.2010.02.020, 20338811.
-
(2010)
Clin Immunol
, vol.136
, pp. 21-29
-
-
Cao, Y.1
Zhao, J.2
Yang, Z.3
Cai, Z.4
Zhang, B.5
Zhou, Y.6
Shen, G.X.7
Chen, X.8
Li, S.9
Huang, B.10
-
40
-
-
77649148760
-
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC
-
10.1097/CJI.0b013e3181bb499f, 20139774
-
Greten TF, Ormandy LA, Fikuart A, Hochst B, Henschen S, Horning M, Manns MP, Korangy F. Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC. J Immunother 2010, 33:211-218. 10.1097/CJI.0b013e3181bb499f, 20139774.
-
(2010)
J Immunother
, vol.33
, pp. 211-218
-
-
Greten, T.F.1
Ormandy, L.A.2
Fikuart, A.3
Hochst, B.4
Henschen, S.5
Horning, M.6
Manns, M.P.7
Korangy, F.8
-
41
-
-
15944410592
-
Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
-
10.1182/blood-2004-06-2410, 15591121
-
Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005, 105:2862-2868. 10.1182/blood-2004-06-2410, 15591121.
-
(2005)
Blood
, vol.105
, pp. 2862-2868
-
-
Lutsiak, M.E.1
Semnani, R.T.2
De Pascalis, R.3
Kashmiri, S.V.4
Schlom, J.5
Sabzevari, H.6
-
42
-
-
83655192112
-
A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice
-
Takeuchi A, Eto M, Yamada H, Tatsugami K, Naito S, Yoshikai Y. A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice. Int J Cancer 2011, 130:365-376.
-
(2011)
Int J Cancer
, vol.130
, pp. 365-376
-
-
Takeuchi, A.1
Eto, M.2
Yamada, H.3
Tatsugami, K.4
Naito, S.5
Yoshikai, Y.6
-
43
-
-
77953730756
-
Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels
-
10.1158/0008-5472.CAN-10-0283, 20501849
-
Zhao J, Cao Y, Lei Z, Yang Z, Zhang B, Huang B. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels. Cancer Res 2010, 70:4850-4858. 10.1158/0008-5472.CAN-10-0283, 20501849.
-
(2010)
Cancer Res
, vol.70
, pp. 4850-4858
-
-
Zhao, J.1
Cao, Y.2
Lei, Z.3
Yang, Z.4
Zhang, B.5
Huang, B.6
-
44
-
-
41949141343
-
Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide
-
10.1615/CritRevImmunol.v28.i2.20, 18540827
-
Brode S, Cooke A. Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. Crit Rev Immunol 2008, 28:109-126. 10.1615/CritRevImmunol.v28.i2.20, 18540827.
-
(2008)
Crit Rev Immunol
, vol.28
, pp. 109-126
-
-
Brode, S.1
Cooke, A.2
-
45
-
-
58249117641
-
CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients
-
10.1002/art.24136, 19116922
-
Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F, Radbruch A, Burmester GR, Riemekasten G. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum 2009, 60:199-206. 10.1002/art.24136, 19116922.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 199-206
-
-
Enghard, P.1
Humrich, J.Y.2
Rudolph, B.3
Rosenberger, S.4
Biesen, R.5
Kuhn, A.6
Manz, R.7
Hiepe, F.8
Radbruch, A.9
Burmester, G.R.10
Riemekasten, G.11
-
46
-
-
27544481941
-
A function for interleukin 2 in Foxp3-expressing regulatory T cells
-
10.1038/ni1263, 16227984
-
Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005, 6:1142-1151. 10.1038/ni1263, 16227984.
-
(2005)
Nat Immunol
, vol.6
, pp. 1142-1151
-
-
Fontenot, J.D.1
Rasmussen, J.P.2
Gavin, M.A.3
Rudensky, A.Y.4
-
47
-
-
68149158968
-
Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus
-
10.4049/jimmunol.0901163, 2730469, 19570829
-
Iikuni N, Lourenco EV, Hahn BH, La Cava A. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J Immunol 2009, 183:1518-22. 10.4049/jimmunol.0901163, 2730469, 19570829.
-
(2009)
J Immunol
, vol.183
, pp. 1518-1522
-
-
Iikuni, N.1
Lourenco, E.V.2
Hahn, B.H.3
La Cava, A.4
|